CID 11035494

Semiglabrinol

Structural Information

Molecular Formula
C21H18O5
SMILES
CC1([C@@H]([C@@H]2[C@H](O1)OC3=C2C4=C(C=C3)C(=O)C=C(O4)C5=CC=CC=C5)O)C
InChI
InChI=1S/C21H18O5/c1-21(2)19(23)17-16-14(25-20(17)26-21)9-8-12-13(22)10-15(24-18(12)16)11-6-4-3-5-7-11/h3-10,17,19-20,23H,1-2H3/t17-,19-,20+/m1/s1
InChIKey
XBKLVCYSINXGAW-RLLQIKCJSA-N
Compound name
(12S,15R,16R)-15-hydroxy-14,14-dimethyl-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.02,7.012,16]hexadeca-1(10),2(7),4,8-tetraen-6-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

350.11542 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 351.122696 178.3
[M+Na]+ 373.104638 190.0
[M-H]- 349.108144 189.9
[M+NH4]+ 368.149243 195.8
[M+K]+ 389.078578 188.0
[M+H-H2O]+ 333.112680 173.5
[M+HCOO]- 395.113621 194.7
[M+CH3COO]- 409.129271 191.1
[M+Na-2H]- 371.090086 182.0
[M]+ 350.11487142 184.1
[M]- 350.11596858 184.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.